Pou’s morphine prescriptions

Pou’s morphine prescriptions were three prescriptions for large amounts of morphine, dated September 1, 2005, and signed by Anna Pou. Seized from Memorial Medical Center’s pharmacy records after Hurricane Katrina, they helped focus the investigation on drug access and possible medication of patients, but did not by themselves establish who received the drugs, in what amounts, or with what intent.

Discovery and Seizure

During a search of the hospital, investigators used a battering ram to enter the Memorial and LifeCare pharmacies. A forensic scientist inventoried the morphine, and agents seized pharmacy records that included the three prescriptions bearing Pou’s signature. The records mattered in a hospital where other drug-related evidence was also found: morphine ampoules were recovered from a LifeCare nursing station, and investigators collected syringes from a seventh-floor room and morphine vials and boxes from a second-floor lobby.

Virginia Rider later turned seized medical items over to the state police crime laboratory for examination for fingerprints and traces of controlled drugs. On the laboratory request form, she identified Pou and recorded her suspicion that multiple patients might have been euthanized at the hospital following the storm. That notation documented the investigative theory, not a finding established by the prescriptions themselves.

Evidence and Its Limits

The prescriptions linked Pou’s signature to large morphine orders dated September 1, but the investigation’s central questions required more than proof that morphine had been prescribed or was present in the hospital. Investigators wanted to know whether particular patients had received the drugs, whether the doses could have contributed to their deaths, and whether any administration was intended to hasten death. The distinction became especially important because some medical records were missing, while the patients’ remains had spent more than a week in the heat before recovery.

Tissue testing offered evidence of drug exposure but did not settle every question. Of eighteen Memorial cases initially discussed by the toxicology laboratory’s director, nine tested positive for morphine and about five or six for midazolam. In a later review of forty-one bodies from Memorial and LifeCare, twenty-three tested positive for morphine, midazolam, or both. These results established drug presence in sampled remains; they did not, without clinical histories and other evidence, establish a specific dose, administration time, or intent.

Competing Interpretations

The condition of the remains complicated interpretation. Frank Minyard initially doubted that autopsies could establish drug levels because decomposition in the heat had made blood sampling impossible. A volunteer pathologist advised that drugs might still be detectable in liver, brain, muscle, or fluid from the abdomen, prompting tissue collection and testing. The later analysis nevertheless remained difficult: postmortem concentrations might not directly reflect levels before death, and a patient’s kidney or liver disease could affect how drugs accumulated or were processed.

Experts disagreed about what could responsibly be inferred. Steven Karch argued that drug concentrations in bodies exposed to prolonged heat could not reliably establish causes of death and recommended leaving the medical cause undetermined. Michael Baden countered that uncertainty about exact dosage did not erase the significance of finding morphine and Versed shortly before death when no competing cause was apparent. Cyril Wecht considered some measured levels exceptionally high and tested whether heat and humidity altered drug concentrations in samples from overdose deaths; his small, unpublished study found no significant difference between exposed and refrigerated samples, but was not definitive.

Investigative Significance

The prescriptions became one link in a larger evidentiary chain: pharmacy records showed that large amounts of morphine had been prescribed under Pou’s name, while seized medication containers, toxicology findings, witness accounts, and incomplete medical records raised separate questions about patient care and deaths. The evidence could support inquiry into access and possible exposure without collapsing those issues into a conclusion about causation or criminal intent.

That distinction shaped the investigation’s stakes. Minyard weighed conflicting expert opinions and the prospect of a trial centered on forensic disagreement, including whether the evidence could overcome reasonable doubt. The prescriptions therefore functioned not as a self-sufficient answer, but as a concrete documentary clue whose meaning depended on uncertain toxicology, patient histories, and the rest of the case.